Clinical Trial COGACCL0933
Title
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Principal Investigator(s)
Details
- Protocol No. COGACCL0933
- Open Date: 11/16/2011
- Staging: Phase III
- Age Group: Both Child and Adult
- Scope: International
- Objective: To determine if prophylaxis with caspofungin administered during periods of neutropenia following chemotherapy for acute myeloid leukemia (AML) is associated with a lower incidence of proven or probable invasive fungal infections (IFI) compared with fluconazole.
- Disease Sites: Leukemia; Pediatric Leukemia
- Therapies: None Specified
- Drugs: Caspofungin; Fluconazole
- Participating Institutions: Vanderbilt University
- Secondary Protocol No: ACCL0933
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
